Stephen Ray Mitchell

Insider Reports History

Location
Washington, DC
Signature
/s/ Stephen Ray Mitchell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Ray Mitchell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. Director Common Stock 97,082 $445,606 $4.59 13 Jun 2025 Direct

Insider Reports Filed by Stephen Ray Mitchell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VNDA Vanda Pharmaceuticals Inc. 13 Jun 2025 1 -$32,130 4 Director 16 Jun 2025, 21:10
VNDA Vanda Pharmaceuticals Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 17:36
VNDA Vanda Pharmaceuticals Inc. 14 Nov 2024 1 -$25,863 4 Director 18 Nov 2024, 17:45
VNDA Vanda Pharmaceuticals Inc. 17 May 2024 2 $0 4 Director 21 May 2024, 16:53
VNDA Vanda Pharmaceuticals Inc. 10 Aug 2023 1 -$39,349 4 Director 11 Aug 2023, 16:36
VNDA Vanda Pharmaceuticals Inc. 08 Jun 2023 2 $0 4 Director 12 Jun 2023, 16:19
VNDA Vanda Pharmaceuticals Inc. 16 Jun 2022 2 $0 4 Director 21 Jun 2022, 16:55
VNDA Vanda Pharmaceuticals Inc. 13 Jun 2022 1 -$25,593 4 Director 14 Jun 2022, 20:37
VNDA Vanda Pharmaceuticals Inc. 09 Sep 2021 5 -$90,040 4 Director 13 Sep 2021, 16:40
VNDA Vanda Pharmaceuticals Inc. 15 Jun 2021 3 -$54,683 4 Director 17 Jun 2021, 17:01
VNDA Vanda Pharmaceuticals Inc. 10 Jun 2021 2 $0 4 Director 14 Jun 2021, 16:36
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .